Hyaluronic Acid Market Share, Sales Price, and Specification forecast to 2028

Hyaluronic Acid Industry Overview

The global hyaluronic acid market size was valued at USD 8.5 billion in 2020 and is projected to witness a compound annual growth rate (CAGR) of 7.19% from 2021 to 2028.

The market is anticipated to witness high growth due to the aging population and the introduction of technologically advanced products. The shift in preference to minimally invasive procedures and rapid results is expected to drive the market in the coming years. Increasing aesthetic consciousness, the introduction of cost-effective treatments and products, and technological advancements are also among the key factors driving the growth of the market. A rise in the number of plastic surgeons and cosmetic clinics is contributing to an increase in the number of aesthetic procedures being performed.

Gather more insights about the market drivers, restrains and growth of the Global Hyaluronic Acid Market

U.S. hyaluronic acid market size, by application, 2018 - 2028 (USD Billion)

The growing adoption of nonsurgical cosmetic procedures including Botox and hyaluronic acid injectables is driving the market. New product developments and rising adoption of business strategies by the key market players including mergers and acquisitions are anticipated to propel market growth over the forecast period. Several health benefits of hyaluronic acid, such as moisture retention, faster wound healing, relief from joint pain, preventing dry eyes &discomfort, and preservation of bone strength, drive the market. The natural aging process, tobacco smoking, and pollution can reduce the amount of hyaluronic acid present in human skin.

Proper use of hyaluronic acid-based supplements and serums can prevent this and improve skin health. The industry is witnessing the introduction of newer technology and geographical expansion through new product approvals and mergers & acquisitions done by the industry players. In March 2018, Bioventus launched a new single-injection joint lubricant, Durolane in the U.S. for the treatment of osteoarthritis pain in the knee. Bioventus offers one-injection (Durolane), three-injection (Gelsyn-3), and five-injection (Supartz FX) hyaluronic acid options for the treatment of knee osteoarthritis pain. 

Browse through Grand View Research’s Medical Devices Industry Research Reports

  • Life Sciences BPO Market: The global life sciences BPO market size was valued at USD 366.3 billion in 2021 and is anticipated to exhibit a compound annual growth rate (CAGR) of 9.2% over the forecast period.
  • Catheter Stabilization Devices Market: The global catheter stabilization devices market size was valued at USD 1.2 billion in 2021 and is projected to grow at a compound annual growth rate (CAGR) of 7.3% during the forecast period 2022-2030. 

Market Share Insights

  • June 2020: AbbVie announced the approval of a new hyaluronic acid product—Juvederm Voluma XC—indicated for improving chin profile in adults. 
  • December 2019: Anika Therapeutics launched its first hyaluronic acid-based surgically delivered regenerative therapy, TACTOSET in the U.S., for the treatment of bone defects caused by trauma or degeneration. 

Key Companies profiled:

 Some of the prominent players in the global hyaluronic acid market include:

  • Allergan
  • Sanofi
  • Genzyme Corp.
  • Anika Therapeutics, Inc.
  • Salix Pharmaceuticals
  • Seikagaku Corporation
  • Hoffmann-La Roche Ag
  • Galderma Laboratories L.P.
  • Zimmer Biomet
  • Smith & Nephew Plc
  • Ferring B.V.
  • Lifecore Biomedical, Llc
  • HTL Biotechnology
  • Shiseido Company, Ltd.
  • Bloomage Biotechnology Corp. Ltd.
  • LG Life Sciences Ltd. (LG Chem.)
  • Maruha Nichiro, Inc. 

Order a free sample PDF of the Hyaluronic Acid Market Intelligence Study, published by Grand View Research. 

Matched content

Editor’s pick

Express Press Release Distribution